Pharma business and healthcare under sanctions: barriers and solutions.
This channel covers the pharmaceutical business and healthcare sector in Russia under international sanctions. It explores regulatory barriers, alternative financing sources, and innovative solutions, making it valuable for pharma executives, investors, and healthcare policymakers.